SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-034146
Filing Date
2024-03-20
Accepted
2024-03-20 16:00:52
Documents
75
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vor-20231231.htm   iXBRL 10-K 2686416
2 EX-23.1 vor-ex23_1.htm EX-23.1 7683
3 EX-31.1 vor-ex31_1.htm EX-31.1 13603
4 EX-31.2 vor-ex31_2.htm EX-31.2 15146
5 EX-32.1 vor-ex32_1.htm EX-32.1 17650
  Complete submission text file 0000950170-24-034146.txt   9365305

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vor-20231231.xsd EX-101.SCH 1192178
78 EXTRACTED XBRL INSTANCE DOCUMENT vor-20231231_htm.xml XML 1530282
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39979 | Film No.: 24767739
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)